HCA Healthcare, Inc.
NYSE:HCAMedical - Care Facilities
-$12.05 today
- Market cap
- $99.51B
- Beta
- 1.13
- P/E (TTM)
- 12.5
- EPS (TTM)
- $29.98
- Dividend yield
- 0.80%
Volume 1.60M
Average 1.37M
HCA Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
HCA Healthcare, Inc.NYSE: HCA
Operating Margin · Q2 FY2026 · quarter ended Jun 2026
Operating margin narrows to 15.2%
Operating margin was 15.2% in Q2 FY2026, down 0.8 pp from a year earlier. On a trailing-twelve-month basis it was 15.5%, up 0.2 pp year over year. Over 3 fiscal years it widened by 0.8 pp.
Context
- Operating margin widened in 2 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether operating margin reaches the consensus estimate from 18 analysts of 15.4% for the fiscal year ending Dec 2026, down from 15.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 15.2%+0.2 pp QoQ
- Last fiscal yearDec 2025
- 15.8%+0.9 pp YoY
- LTMJun 2026
- 15.5%+0.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -0.8 pp | -1.4 pp | -0.6 pp |
| 1 year | +0.9 pp | -0.4 pp | -1.3 pp |
| 3 years | +0.8 pp | +0.5 pp | -0.3 pp |
| 5 years | +2.0 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 15.8%
- Year-over-year change
- +0.9pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15.8% | +0.9pp |
| FY2024 | 2024-12-31 | 14.9% | +0.1pp |
| FY2023 | 2023-12-31 | 14.8% | -0.2pp |
| FY2022 | 2022-12-31 | 15.0% | -1.4pp |
| FY2021 | 2021-12-31 | 16.5% | — |
Operating Margin vs competitors
How HCA compares with its peers on the latest reported figures
- HCA's LTM Jun 2026 operating margin of 15.5% is the 2nd highest of the 6 companies compared; the peer median is 9.0%.
- Its year-over-year change of +0.2 pp is the 4th highest of 6, against a peer median of +0.4 pp.
- Over three fiscal years its change of +0.8 pp compares with a peer median of +0.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 16.8% | -0.8 pp | +4.0 pp | |
| LTM Jun 2026 | 15.5% | +0.2 pp | +0.8 pp | |
| LTM Jun 2026 | 11.4% | +0.4 pp | +4.0 pp | |
ARDTArdent Health Partners, LLC | LTM Mar 2026 | 9.0% | +3.7 pp | +0.9 pp |
| LTM Jun 2026 | 7.4% | +2.8 pp | -3.6 pp | |
| LTM Mar 2026 | -39.8% | -44.5 pp | -86.1 pp | |
| Peer median (excluding HCA) | 9.0% | +0.4 pp | +0.9 pp | |
Competitors are the stored peer set for HCA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 58.75B | 60.23B | 64.97B | 70.6B | 75.6B |
| Cost of Revenue | 36.26B | 37.06B | 39.39B | 41.93B | 44.23B |
| Gross Profit | 22.49B | 23.18B | 25.58B | 28.68B | 31.37B |
| Gross Margin | 38.3% | 38.5% | 39.4% | 40.6% | 41.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 26.78B | 27.69B | 29.49B | 31.17B | 8B |
| Operating Expenses | 12.81B | 14.12B | 15.95B | 18.13B | 19.41B |
| Depreciation & Amortization | 2.85B | 2.97B | 3.08B | 3.31B | 3.52B |
| EBITDA | 14.25B | 13.29B | 12.72B | 13.9B | 15.6B |
| EBITDA Margin | 24.3% | 22.1% | 19.6% | 19.7% | 20.6% |
| Operating Income | 9.68B | 9.05B | 9.63B | 10.55B | 11.97B |
| Operating Margin | 16.5% | 15.0% | 14.8% | 14.9% | 15.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.53B | 1.74B | 1.94B | 2.06B | 2.25B |
| Other Income / Expenses | 155M | (473M) | (1.92B) | (2.02B) | (2.13B) |
| Income Before Tax | 9.83B | 8.58B | 7.71B | 8.52B | 9.83B |
| Pre-Tax Margin | 16.7% | 14.2% | 11.9% | 12.1% | 13.0% |
| Income Tax Expense | 2.11B | 1.75B | 1.62B | 1.87B | 2.05B |
| Net Income | 6.96B | 5.64B | 5.24B | 5.76B | 6.78B |
| Net Margin | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
| EPS (Basic) | 21.51 | 19.44 | 19.24 | 22.27 | 28.62 |
| EPS (Diluted) | 21.16 | 19.15 | 18.96 | 22.00 | 28.38 |
| Weighted Avg Shares | 323.32M | 290.35M | 272.4M | 258.6M | 230.71M |
| Weighted Avg Shares (Diluted) | 328.75M | 294.67M | 276.41M | 261.81M | 230.71M |
HCA Healthcare, Inc.
NYSE:HCA
Intrinsic Alpha fair value
Locked
Current Price
$476.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.